Product category: Other prostheses and orthotic devices
State Of The Art Design This innovative Class II medical device features a biomechanically active but unobtrusive design and state-of-the-art construction materials to simultaneously increase blood flow, offload the wound and protect the foot from further injury . Built-in monitoring software ensures accurate treatment data capture and optimal patient engagement with treatment.
For An Active Life PulseFlowDF is supplied with a left and right pair of comfortable, normal-looking shoes, one concealing the intermittent plantar compression and offloading mechanisms, and the other engineered to ensure good balance and associated patient safety. After treatment the device mechanism is removed and the shoes retained by the patient to minimise the risk of repeat tissue breakdown and continue promotion of a healthy in-shoe environment.
Wearable Technology PulseFlowDF utilises cutting-edge wearable technology to combine two proven treatment strategies - offloading  and intermittent pneumatic compression  - to optimise wound healing in the diabetic foot.
With A Patient Focus Worn during waking hours, the lightweight shin unit is inconspicuous under clothing, minimising the social stigma of treatment often associated with other treatment modalities such as removable cast walkers. In contrast to total contact cast therapy, the entire PulseFlowDF device is removable to enable patients to undertake the essential activities of daily living and to minimise the risk of contralateral tissue damage during sleep.
Founded in 2010, PulseFlow Technologies (PFT) is a rapidly-growing, UK-based medical device company.
Dedicated to improving the quality of life of patients throughout the world and partnering with healthcare professionals to develop cost-effective solutions to unmet medical needs, PFT has worked with clinical experts across the world to develop PulseFlowDF with the aim of saving countless people with diabetes from undergoing lower extremity amputation.
Investor funded since inception, PFT was awarded a grant from the UKs Technology Strategy Board to support the development of PulseFlowDF.